Increased use of higher-cost medicines continues to put pressure on Canadian public drug plans
Imported from official source
A new Patented Medicine Prices Review Board (PMPRB) report finds that prescription drug expenditures by Canadian public drug plans increased by 4.2% in 2020-21, bringing annual spending to $12.3 billion.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
4a200fb7ff9d74e780c13fea7c05d93b- All versions
- Revision history